Effects of Constipation Treatment in Chronic Kidney Disease: A Pilot Feasibility Trial

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

July 31, 2025

Conditions
Chronic Kidney DiseaseConstipation
Interventions
OTHER

Constipation treatment

Lactulose 15 mL (10 g) will be taken orally once daily (in the evening), which can be titrated at 1-week intervals in 15 mL (10 g) increments or decrements up to 60 mL (40 g) as a total daily dose.

Trial Locations (1)

38104

RECRUITING

Memphis VA Medical Center, Memphis

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

University of Florida

OTHER

lead

University of Tennessee

OTHER